TGA Approval

PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial (289794)

ARTG ID

289794

ARTG Name

PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial

Sponsor

Merck Sharp & Dohme (Australia) Pty Ltd

ARTG Date

June 22, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

MERCK SHARP & DOHME (AUSTRALIA) PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-02678-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02057-1

Ingredient Name

letermovir

Empowering clinical research with data-driven insights and AI-powered tools.

PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial (289794) - TGA 批准文号 | MedPath